Weight gain associated with psychotropic drugs

Area of Science:

• Pharmacology
• Psychiatry
• Clinical Medicine

Background:

• Weight gain is a frequent adverse effect of psychotropic medications.
• Clinically significant weight gain elevates risks for cardiovascular disease, diabetes, dyslipidemia, and cancer.
• This can negatively impact treatment compliance, leading to relapse and hospitalization.

Purpose of the Study:

• To review psychotropic drug classes known to induce weight gain.
• To emphasize the importance of patient education and risk assessment.
• To highlight strategies for managing weight gain and ensuring treatment adherence.

Main Methods:

• Literature review focusing on psychotropic drug classes (antipsychotics, antidepressants, mood stabilizers, anxiolytics).
• Analysis of the impact of weight gain on patient health and compliance.
• Discussion of management strategies including lifestyle modifications and physician-patient communication.

Main Results:

• Several classes of psychotropic drugs are associated with significant weight gain.
• Weight gain is linked to severe comorbidities and reduced treatment adherence.
• Proactive management involving patient education and risk assessment is crucial.

Conclusions:

• Clinicians must consider the weight gain potential of psychotropic agents during medication selection.
• Informing patients about potential weight gain and promoting weight management techniques are essential.
• A strong physician-patient relationship is vital for adherence and quality of life.